111 related articles for article (PubMed ID: 20374188)
1. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study.
Cicero AF; Derosa G; Di Gregori V; Bove M; Gaddi AV; Borghi C
Clin Exp Hypertens; 2010 Jan; 32(2):137-44. PubMed ID: 20374188
[TBL] [Abstract][Full Text] [Related]
2. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials.
Appel LJ; Miller ER; Seidler AJ; Whelton PK
Arch Intern Med; 1993 Jun; 153(12):1429-38. PubMed ID: 8141868
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study.
Vernaglione L; Cristofano C; Chimienti S
J Nephrol; 2008; 21(1):99-105. PubMed ID: 18264942
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension.
Russo C; Olivieri O; Girelli D; Azzini M; Stanzial AM; Guarini P; Friso S; De Franceschi L; Corrocher R
J Hypertens; 1995 Dec; 13(12 Pt 2):1823-6. PubMed ID: 8903660
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and new category 'pre-hypertension' in a Japanese population.
Kanauchi M; Kanauchi K; Hashimoto T; Saito Y
Curr Med Res Opin; 2004 Sep; 20(9):1365-70. PubMed ID: 15383184
[TBL] [Abstract][Full Text] [Related]
6. [Influence of some parameters on the blood pressure reduction under treatment: experience from the Hypertension Optimal Treatment Study].
Mallion JM; Baguet JP; Siché JP; Benkritly A
Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1049-53. PubMed ID: 9749163
[TBL] [Abstract][Full Text] [Related]
7. Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in the LIPGENE dietary intervention study.
Gulseth HL; Gjelstad IM; Tierney AC; Shaw DI; Helal O; Hees AM; Delgado-Lista J; Leszczynska-Golabek I; Karlström B; Lovegrove J; Defoort C; Blaak EE; Lopez-Miranda J; Dembinska-Kiec A; Risérus U; Roche HM; Birkeland KI; Drevon CA
Br J Nutr; 2010 Jul; 104(2):160-3. PubMed ID: 20202290
[TBL] [Abstract][Full Text] [Related]
8. Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis.
Yosefy C; Viskoper JR; Varon D; Ilan Z; Pilpel D; Lugassy G; Schneider R; Savyon N; Adan Y; Raz A
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S135-9. PubMed ID: 8872845
[TBL] [Abstract][Full Text] [Related]
9. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
Lungershausen YK; Abbey M; Nestel PJ; Howe PR
J Hypertens; 1994 Sep; 12(9):1041-5. PubMed ID: 7852747
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients.
Holm T; Andreassen AK; Aukrust P; Andersen K; Geiran OR; Kjekshus J; Simonsen S; Gullestad L
Eur Heart J; 2001 Mar; 22(5):428-36. PubMed ID: 11207085
[TBL] [Abstract][Full Text] [Related]
12. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T; Schmidt EB; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive effect and safety evaluation of vegetable drink with peptides derived from sardine protein hydrolysates on mild hypertensive, high-normal and normal blood pressure subjects].
Kawasaki T; Jun CJ; Fukushima Y; Kegai K; Seki E; Osajima K; Itoh K; Matsui T; Matsumoto K
Fukuoka Igaku Zasshi; 2002 Oct; 93(10):208-18. PubMed ID: 12471719
[TBL] [Abstract][Full Text] [Related]
14. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
Magliano MF; Amodeo C; Mion Júnior D; Francischetti E; Lima Júnior E; Nobre F; Chaves H; Ribeiro JM; Spritzer N; Jardim PC
Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
[TBL] [Abstract][Full Text] [Related]
15. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
17. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.
Egert S; Bosy-Westphal A; Seiberl J; Kürbitz C; Settler U; Plachta-Danielzik S; Wagner AE; Frank J; Schrezenmeir J; Rimbach G; Wolffram S; Müller MJ
Br J Nutr; 2009 Oct; 102(7):1065-74. PubMed ID: 19402938
[TBL] [Abstract][Full Text] [Related]
18. Sympathetic hypertensive syndrome: a possible surgically curable type of hypertension.
Chou SH; Kao EL; Lin CC; Chuang HY; Huang MF
Hypertens Res; 2005 May; 28(5):409-14. PubMed ID: 16156504
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
20. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
